MedPath

Protective Effects of EPI-743 on Noise-Induced Hearing Loss

Phase 2
Completed
Conditions
Noise-induced Hearing Loss
Interventions
Drug: Placebo
Registration Number
NCT02257983
Lead Sponsor
Edison Pharmaceuticals Inc
Brief Summary

If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • Healthy adults ages 18-30
  • Abstention from use of Idebenone, CoQ10, Vitamin E and foods or beverages at least 30 days prior to treatment initiation
  • Non-smokers
  • Abstention from alcohol from day 0 and throughout the duration of study
  • Normal audiology exam
  • Subject must be able to swallow size 0 capsules
Exclusion Criteria
  • Allergy to EPI-743 or sesame oil or nuts
  • Any medical disordere that would prevent subject participation
  • Any prescription meds other than for contraception or seasonal allergies
  • Any significant patient medical history (cancer, cardiovascular, pulmonary, cognitive, ADHD, hx. of migraines, neurological, kidney)
  • Fat malabsorption syndromes
  • Anticoagulation thereapy within 30 days of enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboSesame Oil, NF in sealed gelatin capsules to match the test product
EPI-743EPI-743EPI-743 400 mg P.O. TID
Primary Outcome Measures
NameTimeMethod
Pure tone audiometry9 days
Secondary Outcome Measures
NameTimeMethod
Time to recovery following acute noise exposure9 days

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath